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O-002 How a dead duck can be fertile
Moeliker Kees1
1Natural History Museum Rotterdam, Rotterdam, The Netherlands
For witnessing and publishing ‘The first case of homosexual necrophilia in the 
mallard duck (Anas platyrhynchos)’ the speaker was awarded the 2003 Ig Nobel 
Prize in the field of Biology. Thanks to this much coveted award he became 
known as ´The Duck Guy´ and people from all over the globe send him their 
own observations of and/or publications on non-reproductive sexual behavior in 
animals. Here he presents highlights from his ever growing ‘Necrophilia Files’, 
including some severe cases that were overlooked for decades.
To address the topic of human reproduction too, the speaker will also share his 
insights in possibly the most dramatic example of current habitat destruction 
and loss of biodiversity – the disappearance of the once-ubiquitous crab louse 
(Pthirus pubis) due to excessive removal of pubic hair among sexually active 
people.
Keywords: ducks, animal behaviour, non-reproductive sexual behaviour, 
necrophilia, pubic louse
SELECTED ORAL COMMUNICATIONS
SESSION 02: NEW PERSPECTIVES ON EMBRYO SCORING
Monday 15 June 2015 10:00–11:30
O-003 Embryo quality scoring: a correlation between trophectoderm 
development and aneuploidy rate in developing blastocysts
J. Blazek1, M. Large1, V. Pham2, M. Hughes3, T. Gordon4
1Genesis Genetics, R&D/PGS, Houston, TX, U.S.A.
2Fertility Specialists of Houston, Embryology, Houston, TX, U.S.A.
3Genesis Genetics, PGS/PGD, Plymouth, MI, U.S.A.
4Genesis Genetics, PGS/PGD, London, United Kingdom
Study question: Blastocysts cultured for IVF are graded based on stage of 
hatching and organization of the inner cell mass and trophectoderm. Common 
practice is to implant embryos based on quality score in cases where preimplan-
tation genetic screening (PGS) is not used. Is blastocyst embryo quality score 
correlated with chromosomal ploidy?
Summary answer: PGS is critical to improving success rates in implantation 
and live birth during IVF. In cases where PGS is not used prior to implantation, 
embryo quality score can be used to determine the likelihood of embryo aneu-
ploidy based on strong correlations between embryo aneuploidy and in vitro 
trophectoderm development.
What is known already: It is common to select embryos for transfer based 
on morphology during IVF. A retrospective study assessing ploidy and gen-
eral blastocyst morphology suggests that blastocysts graded “excellent” have 
a higher euploid rate than embryos graded “good,” “average,” and “poor,” but 
the value of this information is limited to the general definitions of morphol-
ogy used. A better understanding of how ploidy effects blastocyst morphology 
and organization may help improve efficacy in non-PGS related IVF transfers.
Study design, size, duration: Embryo quality scores have been obtained for 
528 blastocysts from 112 patients all using the same IVF center. Trophectoderm 
biopsies from 528 blastocysts underwent PGS for chromosomal abnormalities 
using array CGH or Next Generation Sequencing and the results were com-
pared to embryo quality score to determine any existent correlations.
Participants/materials, setting, methods: Blastocyst stage embryos were 
scored according to the standard Gardner blastocyst grading system by a single 
embryologist. Amplified trophectoderm biopsies were analyzed using either 
Illumina’s 24-sure array CGH or VeriSeq NGS protocols and chromosomal 
 profiles were compared to embryo score to determine correlates.
INVITED SESSION
SESSION 01: ROBERT G. EDWARDS’ MEMORIAL KEYNOTE SESSION
Monday 15 June 2015 08:30–09:30
O-001 Human reproduction keynote lecture – preconception stress 
increases the risk of infertility: results from a couple-based prospective 
cohort study, the LIFE study
C. D. Lynch1, R. Sundaram2, J. M. Maisog2, A. M. Sweeney3, G. M. Buck 
Louis2
1The Ohio State University College of Medicine, Department of Obstetrics and 
Gynecology, Columbus, U.S.A.
2Eunice Kennedy Shriver National Institute of Child Health and Human 
Development, Division of Intramural Population Health Research, Rockville, 
U.S.A.
3Texas A&M Health Science Center, Department of Epidemiology and Biosta-
tistics, College Station, U.S.A.
Study question: Are women’s stress levels prospectively associated with fecun-
dity and infertility?
Summary answer: Higher levels of stress as measured by salivary alpha-am-
ylase are associated with a longer time-to-pregnancy (TTP) and an increased 
risk of infertility.
What is known already: Data suggest that stress and reproduction are inter-
related; however, the directionality of that association is unclear.
Study design, size, duration: In 2005–2009, we enrolled 501 couples precon-
ceptionally in a prospective cohort study in Michigan and Texas, USA. Couples 
were followed for up to 12 months and through pregnancy if it occurred. A total 
of 401 (80%) couples completed the study and 373 (93%) had complete data 
available for this analysis.
Participants/materials, setting, methods: Enrolled women collected saliva 
the morning following enrollment and then the morning following their first 
observed study menses for the measurement of cortisol and alpha-amylase, 
which are biomarkers of stress. TTP was measured in cycles. Covariate data 
were captured on both a baseline questionnaire and daily journals.
Main results and the role of chance: Among the 401 (80%) women who com-
pleted the protocol, 347 (87%) became pregnant and 54 (13%) did not. After 
adjustment for female age, race, income, and use of alcohol, caffeine, and ciga-
rettes while trying to conceive, women in the highest tertile of alpha-amylase 
exhibited a 29% reduction in fecundity (longer TTP) compared with women 
in the lowest tertile [fecundability odds ratio = 0.71; 95% confidence interval 
(CI) = (0.51, 1.00); p < 0.05]. This reduction in fecundity translated into a more 
than twofold increased risk of infertility among women these women [Relative 
Risk = 2.07; 95% CI = (1.04, 4.11)]. In contrast, we found no association be-
tween salivary cortisol and fecundability.
Limitations, reasons for caution: Due to fiscal and logistical concerns, we 
were unable to collect repeated saliva samples and perceived stress question-
naire data throughout the duration of follow-up. Therefore, we were unable 
to examine whether stress levels increased as women continued to fail to get 
pregnant.
Wider implications of the findings: This is the first US study to demonstrate 
a prospective association between salivary stress biomarkers and TTP, and the 
first in the world to observe an association with infertility.
Study funding/competing interest(s): This study was supported by the In-
tramural Research Program of the Eunice Kennedy Shriver National Insti-
tute of Child Health and Human Development (contracts #N01-HD-3-3355, 
N01-HD-3-3356, N01-HD-3358). There are no conflicts of interest to 
declare .
Trial registration number: NA.
Keywords: fecundity, infertility, stress
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5Humanitas Research Hospital, Department of Gynaecology Division of 
Gynaecology and Reproductive Medicine Humanitas Fertility Center Rozzano, 
Milan, Italy
6Laboratory of Seminology – Sperm Bank, Department of Experimental 
 Medicine University of Rome ‘‘La Sapienza’’, Rome, Italy
7Humanitas Research Hospital, Division of Gynaecology and Reproductive 
Medicine Humanitas Fertility Center Rozzano, Milan, Italy
8Center for Reproductive Medicine and Andrology, University Ernst-Grube-
Str. 40, Halle D-06120, Germany
Study question: To assess whether in men with idiopathic infertility, the sperm 
DNA fragmentation (sDF) improves depending on the FSH receptor (FSHR) 
genotype as assessed by the non-synonymous polymorphisms (SNP) rs6166 
(wild type or p.N680S).
Summary answer: FSH treatment improves sDF in a subgroup of idiopathic 
infertile men, although 40% of these men do not show any significant improve-
ment. The response of sDF, a surrogate marker of sperm quality, together with 
the evaluation of FSHR SNP p.N680S might be useful to predict the response 
to FSH treatment.
What is known already: FSH is fundamental for spermatogenesis and is em-
pirically used to treat male idiopathic infertility. Several studies suggest that 
sDF could be a candidate predictor of response to FSH treatment, in terms of 
probability to conceive. Furthermore, it is widely accepted that the FSHR SNP 
p.N680S influences ovarian response in women and testicular volume in men.
Study design, size, duration: Multicenter, longitudinal, prospective, open-la-
bel, two-arms clinical trial. Subjects enrolled were idiopathic infertile men and 
received 150 IU of recombinant FSH (Gonal f ®) every other day for 12 weeks 
and were then followed-up for further 12 weeks after FSH-withdrawal. Patients 
were evaluated at baseline and at the end of the two phases.
Participants/materials, setting, methods: Eighty-eight men with idiopathic 
male infertility carrier of the homozygous FSHR p.N680S N or S genotype, 
FSH < 8 IU/L and sDF > 15%, were enrolled. 66 patients completed the sDF 
analysis. sDF was centrally evaluated by TUNEL/PI assay coupled to flow cy-
tometry, resolving two different sperm populations, namely: PIbrighter and 
PIdimmer.
Main results and the role of chance: Thirty-seven men (56%) were carriers 
of the p.N680S homozygous-N and 29 (44%) of the homozygous-S genotype, 
respectively. Total sDF (PIbrighter + PIdimmer) was significantly lower at the 
end of the study in patients carriers of the p.N680S-N allele than patients carri-
ers of p.N680S-S allele (p = 0.008). Only in patients carriers of the p.N680S-N 
allele, total sDF decreased significantly from baseline to the end of the study 
(p = 0.021) and this decrease was entirely sustained by the sperm population 
containing vital sperms (i.e., PIbrighter fraction) (p = 0.008). PIdimmer frac-
tion, including only non-vital sperms, was significantly higher in patients car-
riers of the p.N680S-S allele than in carriers of N allele (p = 0.018). Total sDF 
was inversely related to total sperm number (p = 0.020) and progressive sperm 
motility (p = 0.014).
Limitations, reason for caution: The statistical power of the results obtained 
so far is 86.9%, with alpha-error 0.05. This is an interim-analysis.
Wider implications of the findings: The study suggests that FSH treatment 
induces a significant improvement of total sDF in men carriers of the p.N680S 
homozygous N allele. This sDF decrease awaits confirmation, since the study 
will be completed by June 2015.
Study funding/competing interest(s): Funding by commercial/corporate 
company(ies) – The study was supported by unrestricted grant by Merck 
Serono.
Trial registration number: EudraCT number 2010-020240-35.
Keywords: FSH treatment, male infertility, Sperm-DNA fragmentation
O-018 Meiotic studies of ejaculate-derived spermatocytes in 
Robertsonian translocations and small supernumerary marker 
chromosomes carriers using a novel immunocytogenetic technique
S. Ma1, G. Kirkpatrick1, A. H. Ren1, T. Liehr1, V. Chow1
1University of British Columbia, Department of Obstetrics and Gynecology, 
Vancouver, Canada
Study question: What are the meiotic behaviors of the chromosome abnormali-
ties in carriers of Robertsonian translocations (ROBs) and small supernumerary 
marker chromosomes (sSMCs)?
binding globulin (SHBG), oestradiol (E) and inhibin B) in men attending repro-
ductive medicine clinic?
Summary answer: Selected endocrine disrupting chemicals (EDCs), as 
phthalates and their metabolites, can adversely affect the levels of reproduc-
tive hormones measured in serum of men attending reproductive medicine 
clinic, however, there was no evidence confirming the adverse effects of BPA 
or alkylphenols.
What is known already: Reproductive toxicities of BPA, phthalates and alkyl-
phenols have been extensively studied in laboratory animals. A number of re-
cent epidemiologic studies have also suggested toxic effects of BPA and certain 
phthalates on human male reproductive system, but the results of these are not 
conclusive, since there is considerable amount of contradicting data. There are 
no epidemiologic studies to investigate the influence of environmental exposure 
to alkylphenols on human health.
Study design, size, duration: Prospective cohort study included 140 men of 
subfertile couples seeking fertility treatment at university-based tertiary cen-
tre. Data was collected from February 2011 until June 2012. Single-spot urine 
samples were obtained to measure EDCs and creatinine concentration to ac-
count for urinary dilution. Non-fasting blood samples were taken to measure 
hormone levels.
Participants/materials, setting, methods: Gas chromatography/mass spec-
trometry was used to measure: BPA, nonylphenol (NP), octylphenol (OP), di(2-
ethylhexyl)-phthalate (DEHP), dibuthyl-phthalate (DBP), diethyl-phthalate 
(DEP) and their metabolites. Additionally to the measured hormones, free an-
drogen index (FAI), inhibin B/FSH and T/LH ratios were calculated to evaluate 
Sertoli and Leydig cell function, respectively.
Main results and the role of chance: BPA was detected in 98% of all mea-
sured samples. Phthalates with their metabolites were detected in >95% of the 
urine samples, OP was detected in 90% and NP was detected in 79% of samples 
with 0.3 ng/mL limit of detection. After adjusting for confounding factors using 
linear regression models, DEHP and its metabolites showed negative associa-
tion with T (primary metabolite mono-(2-ethyl-5-oxohexyl)phthalate b = -0.61, 
95% CI -1.13 to -0.10), inhibin B (DEHP β = -12.24, 95% CI -23.06 to -1.44) 
and with inhibin B/FSH ratio (DEHP β = -0.19, 95% CI -0.32 to -0.05). DEP 
has shown inverse correlation with LH in univariate analysis, however this was 
insignificant in multivariable model (β = -0.05, 95% CI -0.11 to 0.01). There 
was no influence of BPA or alkylphenols on any of the observed outcomes.
Limitations, reason for caution: Urinary EDC exposure measurements are 
subject to temporal variability. EDCs can also cause negative reproductive ef-
fects by other pathways that are not reflected in altered serum hormone levels. 
Many studied outcomes provide a potential for incidental correlations.
Wider implications of the findings: We have shown that phthalates can ad-
versely influence male reproductive hormone levels. This is in agreement with 
the previous laboratory and some epidemiologic studies showing negative ef-
fects on male reproductive function. BPA and alkylphenols do not seem to have 
a comparable effect, which suggests their minor relevance at environmentally 
present concentrations compared to phthalates. Still, our study was comprised 
of men attending fertility clinic and the results may not be representative of the 
general population.
Study funding/competing interest(s): Funding by national/international 
organization(s) – Slovenian Research Foundation (P3-334-0327).
Trial registration number: NA.
Keywords: endocrine disrupting chemicals, bisphenol A, phthalates, alkylphe-
nols, male reproductive hormones
O-017 FSH treatment improves sperm DNA damage in men with 
idiopathic infertility carriers of the FSH receptor p.N680S homozygous  
N genotype: an interim analysis
S. Manuela1, D. Santi1, F. Linari1, E. Baldi2, M. Cambi2, A. Ferlin3,  
L. Gandini4, P. E. Levi Setti5, F. Lombardo6, M. Marino1, M. Muratori2,  
L. Negri7, E. Pignatti1, G. Rastrelli2, H. M. Behre8
1Unit of Endocrinology, Department of Biomedical Metabolic and Neural 
 Sciences University of Modena and Reggio Emilia Italy, Modena, Italy
2Department of Experimental and Clinical Biomedical Sciences, University of 
Florence, Florence, Italy
3University of Padova, Department of Medicine Unit of Andrology and 
 Reproductive Medicine, Padova, Italy
4Laboratory of Seminology – Sperm Bank, Department of Experimental 
 Medicine University of Rome ‘‘La Sapienza’’, Rome, Italy
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